KJHP
TLSIW icon

K.J. Harrison & Partners’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

K.J. Harrison & Partners’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,990
Closed -$7K – 375
2021
Q4 		$7K Sell
12,990
-34,807
-73% -$32K ﹤0.01% 366
2021
Q3 		$39K Sell
47,797
-30,000
-39% -$27.8K 0.01% 320
2021
Q2 		$79 Buy
77,797
+11,131
+17% +$11K 0.01% 279
2021
Q1 		$73K Buy
+66,666
New +$120K 0.01% 270

Other funds holding TLSIW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

K.J. Harrison & Partners's TLSIW Position: Q1 2022 in Review

K.J. Harrison & Partners sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2022, closing a stake of 12,990 shares — an estimated $7K sold.

K.J. Harrison & Partners first reported a position in TLSIW in Q1 2021 and held it in 4 quarters. The position peaked at $73K in Q1 2021. 26 funds tracked by Wall St. Rank hold TLSIW as of Q1 2022.

  • K.J. Harrison & Partners reported no remaining TriSalus Life Sciences Warrant position as of Q1 2022 after selling out during the quarter.
  • K.J. Harrison & Partners sold 12,990 TriSalus Life Sciences Warrant shares in Q1 2022, an estimated $7K.
  • K.J. Harrison & Partners first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 4 quarters.
  • K.J. Harrison & Partners's TriSalus Life Sciences Warrant position peaked at $73K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2022.

Based on K.J. Harrison & Partners's 13F filing for Q1 2022, filed 21 Apr 2022.